UPDATE: Valeant Pharma (VRX) Exploring Sale of Eye-Surgery Equipment Business - DJ

November 2, 2016 2:48 PM EDT

Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.

(Updated - November 2, 2016 2:50 PM EDT)

Valeant Pharma (NYSE: VRX) is exploring a sale of its eye-surgery equipment business, according to Dow Jones, citing source.

The unit could fetch $2.5 billion, the report said, though discussions are still preliminary.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Hot M&A, Mergers and Acquisitions, Rumors, Trader Talk

Add Your Comment